Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibitory Effects of Cordycepin on Platelet Activation via Regulation of Cyclic Adenosine Monophosphate-downstream Pathway

  • Lee, Dong-Ha (Department of Biomedical Laboratory Science, Korea Nazarene University)
  • Received : 2017.04.25
  • Accepted : 2017.08.20
  • Published : 2017.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Platelet activation is essential at the sites of vascular injury, which leads to hemostasis through adhesion, aggregation, and secretion process. However, potent and continuous platelet activation may be an important reason of circulatory disorders. Therefore, proper regulation of platelet activation may be an effective treatment for vascular diseases. In this research, inhibitory effects of cordycepin (3'-deoxyadenosine) on platelet activation were determined. As the results, cordycepin increased cAMP and cGMP, which are intracellular $Ca^{2+}$-antagonists. In addition, cordycepin reduced collagen-elevated $[Ca^{2+}]_i$ mobilization, which was increased by a cAMP-dependent protein kinase (PKA) inhibitor (Rp-8-Br-cAMPS), but not a cGMP-protein kinase (PKG) inhibitor (Rp-8-Br-cGMPS). Furthermore, cordycepin increased $IP_3RI$ ($Ser^{1756}$) phosphorylation, indicating inhibition of $IP_3$-mediated $Ca^{2+}$ release from internal store via the $IP_3RI$, which was strongly inhibited by Rp-8-Br-cAMPS, but was not so much inhibited by Rp-8-Br-cGMPS. These results suggest that the reduction of $[Ca^{2+}]_i$ mobilization is caused by the cAMP/A-kinase-dependent $IP_3RI$ ($Ser^{1756}$) phosphorylation. In addition, cordycepin increased the phosphorylation of VASP ($Ser^{157}$) known as PKA substrate, but not VASP ($Ser^{239}$) known as PKG substrate. Cordycepin-induced VASP ($Ser^{157}$) phosphorylation was inhibited by Rp-8-Br-cAMPS, but was not inhibited by Rp-8-Br-cGMPS, and cordycepin inhibited collagen-induced fibrinogen binding to ${\alpha}IIb/{\beta}_3$, which was increased by Rp-8-Br-cAMPS, but was not inhibited by Rp-8-Br-cGMPS. These results suggest that the inhibition of ${\alpha}IIb/{\beta}_3$ activation is caused by the cAMP/A-kinase-dependent VASP ($Ser^{157}$) phosphorylation. In conclusion, these results demonstrate that inhibitory effects of cordycepin on platelet activation were due to inhibition of $[Ca^{2+}]_i$ mobilization through cAMP-dependent $IP_3RI$ ($Ser^{1756}$) phosphorylation and suppression of ${\alpha}IIb/{\beta}_3$ activation through cAMP-dependent VASP ($Ser^{157}$) phosphorylation. These results strongly indicated that cordycepin might have therapeutic or preventive potential for platelet activation-mediated disorders including thrombosis, atherosclerosis, myocardial infarction, or cardiovascular disease.

Keywords

References

  1. Barragan P, Bouvier JL, Roquebert PO, Macaluso G, Commeau P, Comet B, Lafont A, Camoin L, Walter U, Eigenthaler M. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheterization and Cardiovascular Interventions. 2003. 59: 295-302. https://doi.org/10.1002/ccd.10497
  2. Borgognone A, Lowe KL, Watson SP, Madhani M. Natriuretic peptides induce weak VASP phosphorylation at Serine 239 in platelets. Platelets. 2014. 25: 1-7. https://doi.org/10.3109/09537104.2013.773969
  3. Butt E, Abel K, Krieger M, Palm, D, Hoppe V, Hoppe J, Walter U. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator stimulated phosphoprotein (VASP) in vitro and in intact human platelets. Journal of Biological Chemistry. 1994. 269: 14509-14517.
  4. Cho HJ, Cho JY, Rhee MH, Park HJ. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner. European Journal of Pharmacology. 2007. 558: 43-51. https://doi.org/10.1016/j.ejphar.2006.11.073
  5. Eigenthaler M, Nolte C, Halbrugge M, Walter U. Concentration and regulation of cyclic nucleotides, cyclic-nucleotidedependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. European Journal of Biochemistry. 1992. 205: 471-481. https://doi.org/10.1111/j.1432-1033.1992.tb16803.x
  6. Gambaryan S, Kobsar A, Rukoyatkina N, Herterich S, Geiger J, Smolenski A, Lohmann SM, Walter U. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. Journal of Biological Chemistry. 2010. 285: 18352-18363. https://doi.org/10.1074/jbc.M109.077602
  7. Halbrugge M, Walter U. Purification of a vasodilator-regulated phosphoprotein from human platelets. European Journal of Biochemistry. 1989. 185: 41-50. https://doi.org/10.1111/j.1432-1033.1989.tb15079.x
  8. Halbrugge M, Friedrich C, Eigenthaler M, Schanzenbacher P, Walter U. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. Journal of Biological Chemistry. 1990. 265: 3088-3093.
  9. Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V, Geiger J, Glazova M, Rohde E, Horak I, Walter U, Zimmer M. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proceedings of the National Academy of Sciences U.S.A. 1999. 96: 8120-8125. https://doi.org/10.1073/pnas.96.14.8120
  10. Horstrup K, Jablonka B, Honig-Liedl P, Just M, Kochsiek K, Walter U. Phosphorylation of focal adhesion vasodilatorstimulated phosphoprotein at $Ser^{157}$ in intact human platelets correlates with fibrinogen receptor inhibition. European Journal of Biochemistry. 1994. 225: 21-27. https://doi.org/10.1111/j.1432-1033.1994.00021.x
  11. Johnston-Cox HA, Ravid K. Adenosine and blood platelets. Purinergic Signalling. 2011. 7: 357-365. https://doi.org/10.1007/s11302-011-9220-4
  12. Kaibuchi K, Sano K, Hoshijima M, Takai Y, Nishizuka Y. Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium. 1982. 3:323-335. https://doi.org/10.1016/0143-4160(82)90020-3
  13. Laurent V, Loisel TP, Harbeck B, Wehman A, Grobe L, Jockusch BM, Wehland J, Gertler FB, Carlier MF. Role of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenes. Journal of Biological Chemistry. 1999. 144:1245-1258.
  14. Li Z, Ajdic J, Eigenthaler M, Du X. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. Blood. 2003. 101: 4423-4429. https://doi.org/10.1182/blood-2002-10-3210
  15. Nieswandt B, Bergmeier W, Eckly A, Schulte V, Ohlmann P, Cazenave JP, Zirngibl H, Offermanns S, Gachet C. Evidence for cross-talk between glycoprotein VI and $G_i$-coupled receptors during collagen-induced platelet aggregation. Blood. 2001. 97: 3829-3835. https://doi.org/10.1182/blood.V97.12.3829
  16. Nishikawa M, Tanaka T, Hidaka H. $Ca^{2+}$-calmodulin dependent phosphorylation and platelet secretion. Nature. 1980. 287: 863-865. https://doi.org/10.1038/287863a0
  17. Pasqui AL, Capecchi PL, Ceccatelli L, Mazza S, Gistri A, Laghi Pasini F, Di Perri T. Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of haemoglobin. Thrombosis Research. 1991. 61: 113-122.
  18. Quinton TM, Dean WL. Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits $Ca^{2+}$ release from platelet membranes. Biochemical and Biophysical Research Communications. 1992. 184: 893-899. https://doi.org/10.1016/0006-291X(92)90675-B
  19. Schaeffer J, Blaustein MP. Platelet free calcium concentrations measured with fura-2 are influenced by the transmembrane sodium gradient. Cell Calcium. 1989. 10: 101-113. https://doi.org/10.1016/0143-4160(89)90050-X
  20. Schwartz SM, Heinmark RL, Majesky MW. Developmental mechanisms underlying pathology of arteries. Physiological Reviews. 1990. 70: 1177-1209. https://doi.org/10.1152/physrev.1990.70.4.1177
  21. Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochemical Pharmacology. 2001. 62: 1153-1161. https://doi.org/10.1016/S0006-2952(01)00760-2
  22. Smolenski A, Bachmann C, Reinhard K, Honig-Liedl P, Jarchau T, Hoschuetzky H, Walter U. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. Journal of Biological Chemistry. 1998. 273: 20029-20035. https://doi.org/10.1074/jbc.273.32.20029
  23. Sudo T, Ito H, Kimura Y. Phosphorylation of the vasodilatorstimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets. Platelets. 2003. 14: 381-390. https://doi.org/10.1080/09537100310001598819
  24. Walter U, Gambaryan S. cGMP and cGMP-dependent protein kinase in platelets and blood cells. Handbook of Experimental Pharmacology. 2009. 191: 533-548.
  25. Wonerow P, Obergfell A, Wilde JI, Bobe R, Asazuma N, Brdicka T, Leo A, Schraven B, Horejsi V, Shattil SJ, Watson SP. Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets. Biochemical Journal. 2002. 364: 755-765. https://doi.org/10.1042/bj20020128